Socs1-derived peptide administered by eye drops prevents retinal neuroinflammation and vascular leakage in experimental diabetes

HIGHLIGHTS

• who: Cristina Hernández et al. from the Universitat Autònoma de Barcelona, Barcelona, Spain, Autonoma University of Madrid (UAM), Madrid, Spain have published the article: SOCS1-Derived Peptide Administered by Eye Drops Prevents Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes, in the Journal: (JOURNAL) of 15,/09/2015
• what: On this basis the aim of this study was to evaluate the effect of a SOCS1-derived peptide administered by eye drops (2 weeks) on and early microvascular abnormalities in a db/db mouse model. The authors provide evidence that a SOCS1 peptidomimetic, administered . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.